ARWR
Arrowhead Pharmaceuticals IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$10.56B
P/E Ratio
—
EPS
$-2.27
Beta
1.29
52W High
$82.26
52W Low
$14.30
50-Day MA
$68.11
200-Day MA
$53.11
Dividend Yield
—
Profit Margin
-48.40%
Forward P/E
111.11
PEG Ratio
-1.32
About Arrowhead Pharmaceuticals Inc
Arrowhead Pharmaceuticals, Inc. develops drugs for the treatment of intractable diseases in the United States. The company is headquartered in Pasadena, California.
Fundamentals
| Revenue (TTM) | $622.01M |
| Gross Profit (TTM) | $622.01M |
| EBITDA | $-196.53M |
| Operating Margin | -191.60% |
| Return on Equity | -42.40% |
| Return on Assets | -7.22% |
| Revenue/Share (TTM) | $4.47 |
| Book Value | $4.37 |
| Price-to-Book | 17.33 |
| Price-to-Sales (TTM) | 16.97 |
| EV/Revenue | 15.83 |
| EV/EBITDA | 27.85 |
| Quarterly Earnings Growth (YoY) | 9.80% |
| Quarterly Revenue Growth (YoY) | -86.40% |
| Shares Outstanding | $140.86M |
| Float | $122.81M |
| % Insiders | 3.76% |
| % Institutions | 88.72% |
Historical Volatility
HV 10-Day
57.05%
HV 20-Day
57.58%
HV 30-Day
55.35%
HV 60-Day
53.38%
HV Rank
44.8%
Volatility is currently expanding
Analyst Ratings
Consensus ($88.17 target)
3
Strong Buy7
Buy2
HoldMore HEALTHCARE Stocks
Data last updated: 5/25/2026